Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

175 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Zidovudine and interferon-alpha combination therapy versus zidovudine monotherapy in subjects with symptomatic human immunodeficiency virus type 1 infection.
Frissen PH, van der Ende ME, ten Napel CH, Weigel HM, Schreij GS, Kauffmann RH, Koopmans PP, Hoepelman AI, de Boer JB, Weverling GJ, et al. Frissen PH, et al. Among authors: van der ende me. J Infect Dis. 1994 Jun;169(6):1351-5. doi: 10.1093/infdis/169.6.1351. J Infect Dis. 1994. PMID: 7910838 Clinical Trial.
High-dose nevirapine in previously untreated human immunodeficiency virus type 1-infected persons does not result in sustained suppression of viral replication.
de Jong MD, Vella S, Carr A, Boucher CA, Imrie A, French M, Hoy J, Sorice S, Pauluzzi S, Chiodo F, Weverling GJ, van der Ende ME, Frissen PJ, Weigel HM, Kauffmann RH, Lange JM, Yoon R, Moroni M, Hoenderdos E, Leitz G, Cooper DA, Hall D, Reiss P. de Jong MD, et al. Among authors: van der ende me. J Infect Dis. 1997 Apr;175(4):966-70. doi: 10.1086/514002. J Infect Dis. 1997. PMID: 9086161
Immune restoration does not invariably occur following long-term HIV-1 suppression during antiretroviral therapy. INCAS Study Group.
Pakker NG, Kroon ED, Roos MT, Otto SA, Hall D, Wit FW, Hamann D, van der Ende ME, Claessen FA, Kauffmann RH, Koopmans PP, Kroon FP, ten Napel CH, Sprenger HG, Weigel HM, Montaner JS, Lange JM, Reiss P, Schellekens PT, Miedema F. Pakker NG, et al. Among authors: van der ende me. AIDS. 1999 Feb 4;13(2):203-12. doi: 10.1097/00002030-199902040-00008. AIDS. 1999. PMID: 10202826
The effect of treatment intensification in HIV-infection: a study comparing treatment with ritonavir/saquinavir and ritonavir/saquinavir/stavudine. Prometheus Study Group.
Gisolf EH, Jurriaans S, Pelgrom J, van Wanzeele F, van der Ende ME, Brinkman K, Borst MJ, de Wolf F, Japour AJ, Danner SA. Gisolf EH, et al. Among authors: van wanzeele f, van der ende me. AIDS. 2000 Mar 10;14(4):405-13. doi: 10.1097/00002030-200003100-00014. AIDS. 2000. PMID: 10770543 Clinical Trial.
Once-daily indinavir plus ritonavir: preliminary results of the PIPO study.
Burger DM, Hugen PW, van der Ende ME, van Wijngaarden P, Aarnoutse RE, Reiss P, Lange JM. Burger DM, et al. Among authors: van der ende me, van wijngaarden p. AIDS. 2000 Nov 10;14(16):2621-3. doi: 10.1097/00002030-200011100-00032. AIDS. 2000. PMID: 11101081 Clinical Trial. No abstract available.
Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study.
Nieuwkerk PT, Sprangers MA, Burger DM, Hoetelmans RM, Hugen PW, Danner SA, van Der Ende ME, Schneider MM, Schrey G, Meenhorst PL, Sprenger HG, Kauffmann RH, Jambroes M, Chesney MA, de Wolf F, Lange JM; ATHENA Project. Nieuwkerk PT, et al. Among authors: van der ende me. Arch Intern Med. 2001 Sep 10;161(16):1962-8. doi: 10.1001/archinte.161.16.1962. Arch Intern Med. 2001. PMID: 11525698
[HIV-1 therapy in the Netherlands; virological and immunological response to antiretroviral therapy].
Jambroes M, Weverling GJ, Reiss P, Danner SA, Jurriaans S, ten Veen JH, van der Ende ME, Schutten M, Schneider MM, Schuurman R, Mulder JW, Kroes AC, Lange JM, de Wolf F; Kliniek en Virologie van het ATHENA-project. Jambroes M, et al. Among authors: van der ende me. Ned Tijdschr Geneeskd. 2001 Aug 18;145(33):1591-7. Ned Tijdschr Geneeskd. 2001. PMID: 11534377 Clinical Trial. Dutch.
175 results